Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients. Preliminary Results

European Addiction Research

Volumn 4, Issue SUPPL. 1, 1998, Pages 8-12

  Bouchez, Jacques ^a   Beauverie, Patrick ^a   Touzeau, Didier ^a  

^a Clinique Liberté   (France)

Author keywords

Buprenorphine; Drug addiction; Methadone; Morphine sulfate; Substitution therapy

Indexed keywords

BUPRENORPHINE; METHADONE; MORPHINE SULFATE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DEPENDENCE; FEMALE; HUMAN; LEGAL ASPECT; MALE; OPIATE ADDICTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SUBSTITUTION THERAPY; TREATMENT OUTCOME; URINE RETENTION; WITHDRAWAL SYNDROME;

EID: 0031757386     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052035     Document Type: Conference Paper

References (9)

1. Jaffe JH, Knapp CM, Circulo DA: Opiates: clinical aspects: in Lowinson JU (ed): Substance abuse - a comprehensive textbook. Williams & Wilkins, 1997, pp 159-165.
2. Eissenberg T, Greenwald MK, Johnson RE, Liebson IA, Bigelow GE, Stitzer ML: Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans. J Pharmacol Exp Ther 1996;276:449-459.
3. van Dyck CH, Rosen MI, Thomas HM, McMahon TJ, Wallace EA, O'Connor PG, Sullivan M, Krystal JH, Hoffer PB, Woods SW: SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatry Res 1994;55(4): 181-191.
4. Kosten TR, Schottenfeld R, Ziedonis D: Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis 1993; 181:358-364.
5. Kanof PD, Aronson MJ, Ness R: Organic mood syndrome associated with detoxification from methadone maintenance. Am J Psychiatry 1993;150(3):423-428.
6. Jasinski DR, Boren JJ, Henningfield JE, Johnson RE, Lange WR, Lukas SE: Progress report from the NIDA addiction research center, Baltimore, Maryland, NIDA Research Monograph 1984;49:69-76.
7. Strain EC, Preston KL, Liebson IA, Bigelow GE: Acute effect of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. J Pharmacol Exp Ther 1992; 261(3):985-993.
8. Jasinski DR, Preston KL: Laboratory studies of buprenorphine in opioid abusers; in Cowan A, Lewis JW (eds): Buprenorphine - treating drug abuse with a unique opioid. Wiley Press Inc, 1995, pp 189-211.
9. Bouchez J, Vigneau J: The French experience - the pharmacist, general practitioner and patient perspective. European Addiction Research (this issue).